Skip to main content

Table 2 Socio-demographic, clinical and baseline characteristics of patients in the Australian and Hong Kong sample (n = 74)

From: The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial

Characteristics

Australian sample (n = 32)

Hong Kong sample (n = 42)

All participants (n = 32)

Intervention (n = 17)

Control (n = 15)

All participants (n = 42)

Intervention (n = 17)

Control (n = 25)

Age (years), mean (SD)

range

63.7 (14.7)

(28–86)

64.6 (15.1)

(42–85)

62.7 (14.7)

(28–86)

72.4 (14)

(35–95)

69.8 (14)

(35–89)

74.2 (16)

(43–95)

BMI (kg/m2), mean (SD)

range

26.1 (7.0)

(17.6–50.8)

24.4 (3.9)

(17.6–31.2)

27.8 (9.0)

(18.1–50.8)

19.7 (3.5)

(14.5–28.2)

19.9 (3.3)

(14.5–28.2)

19.6 (3.6)

(15.1–26.4)

Gender

n(%)

n(%)

n(%)

n(%)

n(%)

n(%)

 Female

16 (50)

8 (47)

8 (53)

26 (61.9)

11 (64.7)

15 (60)

 Male

16 (50)

9 (53)

7 (47)

16 (38.1)

6 (35.3)

10 (40)

Primary cancer type

 Gastrointestinal

8 (25)

2 (12)

6 (40)

20 (47.6)

9 (53.1)

11 (44)

 Gynaecological

3 (9)

1 (6)

2 (13)

3 (7.1)

1 (5.9)

2 (8)

 Lung

2 (6)

2 (12)

0 (0)

12 (28.6)

4 (23.5)

8 (32)

 Skin

4 (13)

3 (18)

1 (7)

–

–

–

 Urological

12 (38)

8 (47)

4 (27)

5 (11.9)

3 (17.6)

2 (8)

 Other (e.g. breast, thyroid, unknown primary)

3 (9)

1 (6)

2 (13)

2 (4.8)

0

2 (8)

Charlson Comorbidity Index Score, mean (SD)

range

6.1 (1.3)

(2–8)

5.9 (1.6)

(2–8)

6.3 (0.6)

(6–8)

–

–

–

Nutritional symptoms

 No appetite

11 (38)

5 (33)

6 (48)

30 (71.4)

10 (58.8)

20 (66.7)

 Feeling full quickly

13 (45)

9 (60)

4 (29)

16 (38.1)

5 (29.4)

11 (44)

 Dry month

3 (10)

1 (7)

2 (14)

16 (38.1)

6 (35.3)

10 (62.5)

 Things taste funny or have no taste

7 (24)

4 (27)

3 (21)

13 (31)

4 (23.5)

9 (36)

 Smell bothers me

2 (7)

2 (13)*

0 (0)*

9 (21.4)

3 (17.6)

6 (24)

 Nausea

5 (17)

5 (33)

0 (0)

8 (19)

1 (5.9)

7 (28)

 Pain

6 (21)

3 (20)

3 (21)

5 (11.9)

2 (11.8)

3 (12)

 Constipation

7 (24)

4 (27)

3 (21)

4 (9.5)

3 (17.6)

1 (4)

 Diarrhoea

3 (10)

2 (13)

1 (7)

   

 Problems with swallowing

2 (7)

1 (7)

1 (1)

4 (9.5)

3 (17.6)

1 (4)

 Mouth sores

1 (3)

0 (0)

1 (7)

   

 Vomiting

2 (7)

2 (13)

0 (0)

3 (7.1)

1 (5.9)

2 (8)

PG-SGA-SF total score, mean (SD) range

8.0 (4.0)

(1–17)

8 (4)

(1–15)

8 (4)

(1–17)

10.2 (4.3)

(1–19)

9.8 (4.6)

(2–19)

10.6 (4.1)

(1–19)

Eating-related distress (single item score), mean (SD) range

3.1 (2.9)

(0–10)

3 (3)

(0–8)

3 (3)

(0–10)

3 (3.1)

(0–8)

2.6 (3.3)

(0–8)

3.2 (3)

(0–8)

Eating-related enjoyment (single item score), mean (SD)

range

3.8 (3.2)

(0–9)

5 (3)

(0–9)

3 (3)

(0–8)

6.8 (3.2)

(0–8)

7.7 (2.9)

(0–8)

6.3 (3.4)

(0–8)

FAACT total score, mean (SD)

range

102.0 (18.8)

(60.3–140.0)

96.66 (22.4)

(60.3–140.0)

108.2 (11.4)

(90.0–127.0)

95.9 (13.6)

(65.7–121)

101.6 (15.7)*

(74–121)

92.0 (10.5)*

(66–114)

FAACT cachexia subscale, mean (SD)

range

30.3 (8.0)

(20.0–46.0)

29.01 (7.7)

(20.0–46.0)

31.69 (8.3)

(21.0–45.8)

31 (5.6)

(21–42)

32.4 (5.4)

(25–42)

30.0 (5.6)

(21–40)

  1. *P < 0.05